Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
How can we make measures of psychotic depression symptoms more clinically useful?Fava, M.Acta psychiatrica Scandinavica, 2014-03, Vol.129 (3), p.161-162 [Periódico revisado por pares]United States: Blackwell Publishing LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioningLyall, A E ; Pasternak, O ; Robinson, D G ; Newell, D ; Trampush, J W ; Gallego, J A ; Fava, M ; Malhotra, A K ; Karlsgodt, K H ; Kubicki, M ; Szeszko, P RMolecular psychiatry, 2018-03, Vol.23 (3), p.701-707 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
3 |
Material Type: Artigo
|
Weight gain and antidepressantsFava, MThe journal of clinical psychiatry, 2000, Vol.61 Suppl 11, p.37-41 [Periódico revisado por pares]United States: Physicians Postgraduate PressTexto completo disponível |
|
4 |
Material Type: Artigo
|
The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey ReplicationFava, M ; Hwang, I ; Rush, A J ; Sampson, N ; Walters, E E ; Kessler, R CMolecular psychiatry, 2010-08, Vol.15 (8), p.856-867 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
5 |
Material Type: Artigo
|
Use of functional imaging across clinical phases in CNS drug developmentBorsook, D ; Becerra, L ; Fava, MTranslational psychiatry, 2013-07, Vol.3 (7), p.e282-e282 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
|
6 |
Material Type: Artigo
|
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSIONFava, Maurizio ; Davidson, Katharine G.The Psychiatric clinics of North America, 1996-06, Vol.19 (2), p.179-200 [Periódico revisado por pares]Orlando, FL: Elsevier IncTexto completo disponível |
|
7 |
Material Type: Artigo
|
Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health systemClements, C C ; Castro, V M ; Blumenthal, S R ; Rosenfield, H R ; Murphy, S N ; Fava, M ; Erb, J L ; Churchill, S E ; Kaimal, A J ; Doyle, A E ; Robinson, E B ; Smoller, J W ; Kohane, I S ; Perlis, R HMolecular psychiatry, 2015-06, Vol.20 (6), p.727-734 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
8 |
Material Type: Artigo
|
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patientsFava, M ; Johe, K ; Ereshefsky, L ; Gertsik, L G ; English, B A ; Bilello, J A ; Thurmond, L M ; Johnstone, J ; Dickerson, B C ; Makris, N ; Hoeppner, B B ; Flynn, M ; Mischoulon, D ; Kinrys, G ; Freeman, M PMolecular psychiatry, 2016-10, Vol.21 (10), p.1372-1380 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
9 |
Material Type: Artigo
|
Psychosocial stressors and the prognosis of major depression: a test of Axis IVGilman, S. E. ; Trinh, N.-H. ; Smoller, J. W. ; Fava, M. ; Murphy, J. M. ; Breslau, J.Psychological medicine, 2013-02, Vol.43 (2), p.303-316 [Periódico revisado por pares]Cambridge, UK: Cambridge University PressTexto completo disponível |
|
10 |
Material Type: Artigo
|
A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorderPapakostas, G I ; Johe, K ; Hand, H ; Drouillard, A ; Russo, P ; Kay, G ; Kashambwa, R ; Hoeppner, B ; Flynn, M ; Yeung, A ; Martinson, M A ; Fava, MMolecular psychiatry, 2020-07, Vol.25 (7), p.1569-1579 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |